Zobrazeno 1 - 10
of 10
pro vyhledávání: '"You-Bing Zheng"'
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
γδ T cells are one of only three immune cell types that express antigen receptors that undergo somatic recombination, and they contribute to immune responses to infection, cellular transformation, and tissue damage. As a “bridge” between the in
Externí odkaz:
https://doaj.org/article/d749397833734b20a810ff9a689116d4
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 141:1103-1108
To evaluate the efficacy and safety of arsenic trioxide transarterial chemoembolization and intravenous administration in unresectable hepatocellular carcinoma with lung metastasis.A single-blind, two-parallel group, randomized trial was conducted at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9840a6bc0d10af61d88b3e34dcf9bef
https://doi.org/10.1007/s00432-014-1866-1
https://doi.org/10.1007/s00432-014-1866-1
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 14:5527-5531
Background and Aim: Increasing evidence correlates the presence of systemic inflammation with poor survival in patients with hepatocellular carcinoma (HCC). The aim of this study was to investigate the prognostic significance of the blood neutrophil-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99767aa272fcc09656a83fd0965a0323
https://doi.org/10.7314/apjcp.2013.14.9.5527
https://doi.org/10.7314/apjcp.2013.14.9.5527
Publikováno v:
Medical Oncology. 31
The aim of this study was to clarify circulating tumor cells (CTCs) count could reflect the effect of postoperative transarterial chemoembolization therapy. A single-blind, two-parallel group, randomized trial was conducted in Guangdong General Hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b0a9218200e48a6dca847d99cc97dfb
https://doi.org/10.1007/s12032-014-0277-0
https://doi.org/10.1007/s12032-014-0277-0
Autor:
Sirui Fu, Bao-Shan Hu, He Xu, You-Bing Zheng, Yan Zhao, Wei Zhao, Jian-Wen Huang, Li Yong, Ligong Lu, Bing Liu, Mei-Xiao Zhan
Publikováno v:
Medical Oncology. 31
Kinase insert domain receptor (KDR) is the principal receptor that promotes the pro-angiogenic action of vascular endothelial growth factor and has been the principal target of anti-angiogenic therapies. Our aim was to determine whether single-nucleo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89610335d90b192a9dca1a95c7022843
https://doi.org/10.1007/s12032-014-0209-z
https://doi.org/10.1007/s12032-014-0209-z
Publikováno v:
Oncology. 89(1)
Objectives: It was the aim of this study to find an optimal therapeutic regimen of transarterial chemoembolization (TACE) by comparing the efficacy of chemoembolization with different anticancer agents in hepatocellular carcinoma (HCC) patients. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e286b7e16d7f29fa1db4b412f9fdecd2
https://pubmed.ncbi.nlm.nih.gov/25613214
https://pubmed.ncbi.nlm.nih.gov/25613214
Publikováno v:
Medical Oncology. 31
The aim of this study was to clarify circulating tumor cells (CTCs) count could reflect the effect of postoperative transarterial chemoembolization therapy. A single-blind, two-parallel group, randomized trial was conducted in Guangdong General Hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ed53adfdcf14bda4adb025ddde62013
https://doi.org/10.1007/s12032-014-0175-5
https://doi.org/10.1007/s12032-014-0175-5
Autor:
Jian-wen, Huang, Bing, Liu, Bao-shan, Hu, Yong, Li, Xu, He, Wei, Zhao, You-bing, Zheng, Li-gong, Lu
Publikováno v:
Medical oncology (Northwood, London, England). 31(9)
The aim of this study was to clarify circulating tumor cells (CTCs) count could reflect the effect of postoperative transarterial chemoembolization therapy. A single-blind, two-parallel group, randomized trial was conducted in Guangdong General Hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fccae5e32722dbe3845aa8d2222e2783
https://pubmed.ncbi.nlm.nih.gov/25323939
https://pubmed.ncbi.nlm.nih.gov/25323939
Autor:
Ligong Lu, Bao-shan Hu, Mei-Xiao Zhan, Xu He, You-bing Zheng, Wei Zhao, Jian-Wen Huang, Bing Liu, Yong Li
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 35(11)
Kinase insert domain receptor (KDR) is the principal receptor that promotes the proangiogenic action of vascular endothelial growth factor and is involved in the tumorigenesis and progression of many malignancies, including hepatocellular carcinoma (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee4d2e6993ed4f28deb65d410d5c24f9
https://pubmed.ncbi.nlm.nih.gov/25123269
https://pubmed.ncbi.nlm.nih.gov/25123269
Autor:
Qing-wen Meng, Yong Li, Xu He, Bao-shan Hu, You-bing Zheng, Wei Zhao, Jian-Wen Huang, Ligong Lu, Bing Liu
Publikováno v:
Medical oncology (Northwood, London, England). 31(3)
We aimed to elucidate whether serum VEGFR2 concentration before and after transarterial chemoembolization (TACE) can predict survival in patients with unresectable hepatocellular carcinoma (HCC). Serum VEGFR2 concentrations were serially measured in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6809615cb6829b760083e2f003a9141
https://pubmed.ncbi.nlm.nih.gov/24442426
https://pubmed.ncbi.nlm.nih.gov/24442426